5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed episode artwork

EPISODE · Dec 24, 2022 · 21 MIN

5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed

from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH

Sample size games, primary endpoint, head to head trials in oncology Rate this podcast on itunes Coming next is Triangle trial

Episode metadata supplied by the publisher feed · Published Dec 24, 2022

Embed this episode

NOW PLAYING

5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed

0:00 21:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plenary Session - inactive due to federal service?

This episode is 21 minutes long.

When was this Plenary Session - inactive due to federal service episode published?

This episode was published on December 24, 2022.

Can I download this Plenary Session - inactive due to federal service episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!